‘Sleep psychologist’ directory to assist with de-prescribing The newly launched provider registry helps GPs refer insomnia patients to CBT – in a move away from prescribing benzodiazepines.
Exercise most benefits those with highest OA pain: Study Research indicates physical activity may be particularly important to manage depression in people with greater osteoarthritis-related pain.
‘A risky proposition’: pharmacy prescribing expands further GPs are growing increasingly worried for their patients, as pharmacy prescribing programs are taking hold in every corner of the country.
Exercise must be ‘core treatment’ for depression: Study Researchers have urged GPs to prescribe physical activity alongside traditional interventions, with yoga and strength training especially beneficial.
Trial aims to improve therapy access for insomnia The pilot is designed to better support GPs with management, referral pathways and non-drug interventions for patients with insomnia.
Push to assess COVID-19 treatment eligibility prior to infection College launches new guidelines to support GPs assessing the best approach for vulnerable patients before they test positive.
Paxlovid goes on PBS as GPs urged to avoid private prescribing This is the first week the COVID-19 treatment has been available on the PBS, meaning two oral antiviral medications can now be prescribed by general practice.
COVID treatment update: Answers to what HPs are asking NPS MedicineWise speaks with members of the National COVID-19 Clinical Evidence Taskforce Guidelines Leadership Group, who provide an update on the new antiviral treatments and answer some frequently asked questions.
At-risk COVID patients in WA directed to GPs for antiviral access The WA Department of Health has changed the mechanism for prescribing antiviral treatments through its COVID Care at Home program.
HANDI site ‘more complete’ with new patient resources The new resources complement existing resources within HANDI and are aimed at helping GPs provide non-drug intervention-based care.